Yuyu Pharma, Inc. 000220
KRX · South Korea · Health Technology
KRW 3,780.00-20.00 (-0.53%)
Market closed· · KRW · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · KRW · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Robert Wonsang Yu, CEO of Yuyu Pharma (KRX: 000220), attended Amazon Accelerate 2026 in Seattle from September 22 to 24 to explore how Amazon's newest AI, consumer data, advertising and logistics tools can help grow Ari's Purrfect, Yuyu Pharma's U.S. feline-health brand.
Yuyu Teijin Medicare, a home healthcare joint venture between Yuyu Pharma of Korea and Teijin Pharma of Japan, has completed a pilot delivery of medical supplies by drone to a ventilator patient living on a remote Korean island.
Yuyu Pharma (KRX: 000220) has completed a major expansion of solar power at its manufacturing facility in Korea, bringing the site's total on-site solar capacity to approximately 1 megawatt (MW). The new 869-kilowatt (kW) solar system builds on earlier installations of 30 kW in 2020 and 96.6 kW in 2021. Together, the solar systems are expected to provide more than 30% of the electricity used at the manufacturing facility.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.